Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes.

Molecular and Cellular Endocrinology
Mervi E HyvönenS Lehtonen

Abstract

Podocyte injury plays an important role in the development of diabetic nephropathy. Podocytes are insulin-responsive and can develop insulin resistance, but the mechanisms are unknown. To study the role of CD2-associated protein (CD2AP) in podocyte injury, we performed a yeast two-hybrid screening on a glomerular library, and found that CD2AP bound to SH2-domain-containing inositol polyphosphate 5-phosphatase 2 (SHIP2), a negative regulator of insulin signalling. SHIP2 interacts with CD2AP in glomeruli and is expressed in podocytes, where it translocates to plasma membrane after insulin stimulation. Overexpression of SHIP2 in cultured podocytes reduces Akt activation in response to insulin, and promotes apoptosis. SHIP2 is upregulated in glomeruli of insulin resistant obese Zucker rats. These results indicate that SHIP2 downregulates insulin signalling in podocytes. The upregulation of SHIP2 in Zucker rat glomeruli prior to the age of onset of proteinuria suggests a possible role for SHIP2 in the development of podocyte injury.

References

May 1, 1987·Diabetic Medicine : a Journal of the British Diabetic Association·K Borch-JohnsenJ Nerup
Jul 11, 1998·The Journal of Biological Chemistry·T HabibS J Decker
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·K H KirschH Hanafusa
May 31, 2001·Kidney International·M W SteffesUNKNOWN International Diabetic Nephropathy Study Group
Jul 18, 2001·The Journal of Clinical Investigation·T TakedaM G Farquhar
Feb 22, 2002·Journal of the American Society of Nephrology : JASN·Moin A SaleemPeter Mundel
Jun 25, 2002·Annals of the New York Academy of Sciences·Eva TomásNeil B Ruderman
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Tuula PalménHarry Holthöfer
Sep 10, 2002·American Journal of Physiology. Renal Physiology·Sanna LehtonenEero Lehtonen
Feb 25, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Michal GroppBenjamin E Reubinoff
May 9, 2003·American Journal of Physiology. Renal Physiology·Kumar SharmaStephen R Dunn
Jul 2, 2003·Molecular and Cellular Biology·Tobias B HuberThomas Benzing
Jan 18, 2005·Nature Medicine·Mark W SleemanDavid J Glass
Jun 21, 2005·The International Journal of Biochemistry & Cell Biology·Jennifer M DysonChristina A Mitchell
Oct 27, 2005·Diabetes·Richard J M CowardMoin A Saleem
Apr 13, 2007·Physiological Reviews·David B SavageGerald I Shulman
Sep 7, 2007·Kidney International·Y MiyazakiR A DeFronzo
Sep 14, 2007·Kidney International·D VerzolaG Garibotto

❮ Previous
Next ❯

Citations

May 28, 2014·Nature Reviews. Nephrology·Alessia FornoniJeffrey B Kopp
Nov 30, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Abigail Lay, Richard J Coward
Oct 30, 2015·Molecular Biology of the Cell·Qian YangGuohua Ding
Mar 10, 2016·Journal of Nephrology·Adriana Izquierdo-LahuertaGema Medina-Gómez
Feb 11, 2011·Diabetes/metabolism Research and Reviews·Nicole StiegerMario Schiffer
May 8, 2013·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jingwei XieIsabelle Pirson
Apr 11, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·M E HyvönenP-H Groop
May 30, 2012·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·William's Elong EdimoChristophe Erneux
Nov 30, 2012·Clinical Science·Lorna J Hale, Richard J M Coward
May 23, 2015·BioMed Research International·Mervi E HyvönenSanna Lehtonen
Jul 1, 2015·Current Diabetes Reports·Neil G DochertyCarel W le Roux
Feb 16, 2016·Scientific Reports·Pauliina SaurusSanna Lehtonen
Oct 27, 2017·Current Opinion in Nephrology and Hypertension·Pedro Geraldes
May 8, 2015·Cell Death & Disease·P SaurusS Lehtonen
Feb 27, 2016·F1000Research·Jochen Reiser, Mehmet M Altintas
Oct 16, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zydrune Polianskyte-PrauseSanna Lehtonen
Jul 22, 2016·Cell Death & Disease·S KuuselaS Lehtonen
Nov 22, 2014·Current Opinion in Nephrology and Hypertension·Richard Coward, Alessia Fornoni
Feb 6, 2020·Diabetes, Obesity & Metabolism·John R PetrieIan W Campbell
Dec 3, 2016·Chembiochem : a European Journal of Chemical Biology·Mark P ThomasBarry V L Potter
Apr 25, 2018·Frontiers in Endocrinology·Anita A Wasik, Sanna Lehtonen
Mar 28, 2013·American Journal of Physiology. Endocrinology and Metabolism·Nicolas DrapeauPedro Geraldes
Oct 31, 2019·Scientific Reports·Hae Nim LeeJihye Seong
Aug 4, 2020·Journal of Biomaterials Applications·Xinlu YuanAnqing Du
Nov 8, 2015·Journal of Cell Science·Tuomas A TolvanenSanna Lehtonen
Jul 19, 2021·Biochemical Pharmacology·Dorota Rogacka, Agnieszka Piwkowska

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Basement Membranes

Basement membranes are thin, specialized extracellular matrices surrounding most tissues in all metazoans. Here is the latest research on basement membranes.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.